US 10316105
Anti-TIE2 antibodies and uses thereof
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10316105 (Anti-TIE2 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61K39/3955